Notice· 31 May 2026
Notice of Special General Meeting published
The board called a Special General Meeting for 1 Ashad 2083 at 8:00 AM at the registered office, with an agenda covering a capital increase, amended articles and a public share issue.
Press & Announcements
Corporate & Clinical News
Official press statements, regulatory approvals, plant facility updates, and medical symposia from G.D. Pharmaceuticals.
Investor· 1 Ashad 2083
Special General Meeting held on proposed IPO
G.D. Pharmaceuticals Limited held a Special General Meeting at its registered office in Tripureshwor, Kathmandu. Shareholders considered proposals to increase the authorised and issued capital, amend the Memorandum and Articles of Association, and issue shares to the general public through an IPO.
G.D. Press Secretariat · Tinkune, Kathmandu
Company· 2026
G.D. Pharmaceuticals becomes a public limited company
The company, formerly G.D. Pharmaceutical Pvt. Ltd., has converted to a public limited company ahead of offering its shares to the public.
Upcoming Milestones & Events
Coming soon
IPO updates
Coming soon
CSR activities
Coming soon
Health camps
Had a side effect from one of our medicines?
Tell us. Every report helps us keep our products safe. In an emergency, see a doctor first.